Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .

Essential

These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.
Statistics

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external video platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name Youtube
Purpose External media

Synergy Group 3

SARS-CoV-2 vaccines: a balance between protection and immunopathology

The worldwide crisis caused by the SARS-CoV-2 pandemic will only be overcome by herd immunity.
Effective vaccines are becoming available, but neither the correlates nor durability of immune protection have been defined. Moreover, pre-existing antiviral immunity bears the risk of unwanted induction of immunopathology upon exposure.
Thus, a profound understanding of protective versus pathologic antiviral immunity is required.
Here, we define adaptive immune responses during the natural course of infection in comparison to that induced by vaccines. Thereby, we gain important mechanistic insights into antiviral immunity to manage the current pandemic and to be better prepared for potential future pandemics.

to top
powered by webEdition CMS